Adult mice have two easily recognizable subsets of B cells: the predominant resting population of the spleen, called B-2, and those called B-l, which predominate in coelomic cavities and can express CDS. Some antibody specificities appear to be unique to the B-1 population. Cells expressing antibody specific for phosphatidyl choline (PtC) are the most frequent, comprising 2-10% of peritoneal B cells in normal mice. To understand the basis for the segregation of the anti-PtC specificity to this population, we have produced transgenic (Tg) mice expressing the rearranged VH12 and VD genes of a PtC-specific B-1 cell lymphoma. We find that V.12-Tg and Va12/VD double-Tg mice develop very high numbers of PtC-specific peritoneal and splenic B cells. These cells have the characteristics of B-1 cells; most are CD5 +, and are all IgM ~, B2201~ and CD23-. In the peritoneum these cells are also CD11b +. In addition, adult mice have many splenic B cells (up to one third of Tg § cells) that express the V.12 Tg but do not bind PtC, presumably because they express a V~ gene other than V~4. These cells appear to be B-2 cells; they are CD23 +, CD11b-, IgM 1~ B220 hi, and CD5-. Thus, mice given either the VH12 Tg alone or together with the V~4 Tg develop a large population of PtC-specific B cells which belong exclusively to the B-1 population. Since B-2 cells can express the V.12 and V~4 gene separately, we interpret these data to indicate that the events leading to the segregation of PtC-specific B cells to the B-1 population in normal mice are initiated after Ig gene rearrangement and expression. These data are discussed with regard to hypotheses of the origin of B-1 cells. We also find that VH12-Tg mice have a marked decrease in the generation of Tg-expressing B cells in adult bone marrow, but not newborn liver. We speculate that this may be related to positive selection of V.12-expressing B cells during differentiation.
Summal'y
Adult mice have two easily recognizable subsets of B cells: the predominant resting population of the spleen, called B-2, and those called B-l, which predominate in coelomic cavities and can express CDS. Some antibody specificities appear to be unique to the B-1 population. Cells expressing antibody specific for phosphatidyl choline (PtC) are the most frequent, comprising 2-10% of peritoneal B cells in normal mice. To understand the basis for the segregation of the anti-PtC specificity to this population, we have produced transgenic (Tg) mice expressing the rearranged VH12 and VD genes of a PtC-specific B-1 cell lymphoma. We find that V.12-Tg and Va12/VD double-Tg mice develop very high numbers of PtC-specific peritoneal and splenic B cells. These cells have the characteristics of B-1 cells; most are CD5 +, and are all IgM ~, B2201~ and CD23-. In the peritoneum these cells are also CD11b +. In addition, adult mice have many splenic B cells (up to one third of Tg § cells) that express the V.12 Tg but do not bind PtC, presumably because they express a V~ gene other than V~4. These cells appear to be B-2 cells; they are CD23 +, CD11b-, IgM 1~ B220 hi, and CD5-. Thus, mice given either the VH12 Tg alone or together with the V~4 Tg develop a large population of PtC-specific B cells which belong exclusively to the B-1 population. Since B-2 cells can express the V.12 and V~4 gene separately, we interpret these data to indicate that the events leading to the segregation of PtC-specific B cells to the B-1 population in normal mice are initiated after Ig gene rearrangement and expression. These data are discussed with regard to hypotheses of the origin of B-1 cells. We also find that VH12-Tg mice have a marked decrease in the generation of Tg-expressing B cells in adult bone marrow, but not newborn liver. We speculate that this may be related to positive selection of V.12-expressing B cells during differentiation.
~ ult mice contain, at least, two stable, distinct populations of B lymphocytes (for reviews see references 1-3); these have been designated B-1 (formerly CD5 + , Ly-1 B) and B-2 (formerly conventional) (4) . B-1 cells are the predominant population in the peritoneal cavity, and B-2 cells are the predominant population in spleen and lymph nodes. One of the notable differences between B-1 and B-2 cells are their expressed V. repertoires and Ig specificities (5) . Antigens recognized predominantly or exclusively by the mlgM of B-1 cells include phosphatidyl choline (PtC), 1 DNA, Ig (rheumatoid factor), and common bacterial carbohydrate antigens (e.g., phosphorylcholine [6] [7] [8] [9] [10] ). Probably the most frequent Ig specificity expressed by B cells is that for the ubiquitous self-membrane phospholipid, PtC (6, 11) . In normal mice, this specificity is expressed by 2-10% of peritoneal B cells and ",,0.3% of normal splenic B cells (6) and appears to be expressed exclusively by B-1 cells (6, 8, 12, 13) . IgM specific for PtC is encoded predominantly by either of two combinations of VH and VL: VH11 and a V~9 gene, or V.12 and a VD gene (13) (14) (15) (16) (17) (18) . Each V gene pair is represented about equally in the adult B-1 population of B10.H-2aH-4 b (2~4 b) mice (14) . These findings and the restriction of the V. CDR3 sequences of anti-PtC B-1 cells argue that these cells in the adult are antigen-selected (17, 19) .
The origins of B-1 and B-2 cells are controversial. Two views have been offered. The more long-standing view is that B-1 and B-2 cells arise from distinct progenitors committed to their respective lineages before expression of Ig (20, 21; identity of the VDJ. segment in the clone used for transfection and microinjection was confirmed by dideoxy sequence analysis. This fragment initially contained an intact # switch region upstream of the C# exons. However, deletions in the # switch region occurred during replication such that the size of the EcoRI C/L fragment in the DNA used for microinjections ranged from 12.0 to 9.7 kb.
The ability of the V.12.CH27-C/~ construct to encode a function IgM protein was tested by transfection into an Ig heavy-chain loss variant of CH12 (IgM b) (32) . The plasmid was linearized by digestion with SfiI and electroporated into cells. Stable transfectants were selected in the presence of 0.4 mg/ml G418 (Geneticin; Sigma Chemical Co., St. Louis, MO). Expression was analyzed by immunofluorescence for mIgM ~ and by ELISA for secreted IgM (see below; data not shown).
V,4.CH27-C~ Construct. The V~4.CH27-C~ construct contains the V~4-J~4-C~ genes expressed by CH27.LX (28) . Genomic DNA from CH27.LX was digested to completion with BamHI and size fractionated on 0.6% agarose gel. The fraction containing the 8.5-kb-productive V~-J~ rearrangement was identified with the J~-C~ probe pEC~ (33) and cloned into the BamHI site of EMBL3 (Promega Corp., Madison, WI). Positive clones were identified by hybridization to a J~-specific probe (a 2.9-kb HindIII fragment isolated from pEC,) and plaque purified. The V~4-J~4-C~ fragment was then cloned into the BamHI site in a modified pSV2-Neo vector (this vector has the polylinker described above except that the vector SfiI site was retained). The identity of the VK4-J~4 segment in the clone used for transfection and microinjection was confirmed by dideoxy sequence analysis (28) .
The ability of the V~4-J~4-C~ fragment to encode a functional K light chain was tested by transfection into P3-X63-Ag8.653, a nonsecreting myeloma line (34) . The plasmid was linearized with NotI and electroporated into cells. Stable transfectants were selected in the presence of 0.4 mg/ml G418. Transfectants were selected for expression of secreted x light chain (analyzed by ELISA). The V~4-JK4-C~ fragment was shown to pair with the V.12.CH27-C/x-encoded heavy chain by cotransfecting myeloma cells with both constructs. Stable transfectants secreting IgM,~c Ig were identified by ELISA.
Microinjection and Founder Tg Mice. The V.12.CH27-C# and V~4-J~4-C~ fragments were isolated from vector DNA by digestion with SalI and BamHI, respectively, and purified by agarose gel electrophoresis. The DNA was microinjected separately into (C57BL/6 x SJL)F2 (IgM b) fertilized eggs by the National Tramgenic Facility of DNX, Inc. (Princeton, N J). Mouse lines carrying either the V.12.CH27-C# or the V~4-J~4-C~ Tg were identified by Southern blot analysis of taft DNA by use of the pJll or pEC~ probes, or by PCR with, for V.12, framework 1-(CTTCCTTAC-CTGCTCTATTACTGGTTTCC; bp 54-82 of V.12) and J,-specific (CTATCCTTACAGAAAAGCTTCTGCAGC; 95 bp 3' of J.1) amplimers and, for V~4, V~4 (5' AGCTCAAGTATAAGTTC-CAATTACTTGCAT 3') and J,4 (5' GTTACCCAAACAGAAC-CAAAACGTCACA 3') amplimers.
Mice. Lines of Tg mice have been maintained by backcrossing male Tg + mice with female 2q b mice. Tg + offspring were identified by PCR analysis or serology. Mice are bred and maintained in our own pathogen-free mouse colony.
Hybridomas. Hybridomas from V.12-Tg mice were prepared as described previously (14) . Briefly, spleen cells were cultured overnight in R.PMI 1640 medium containing 50/zg/ml LPS and 20 #g/ml dextran sulfate. Cells were harvested and fused by use of polyethylene glycol with the Ag8.653 myeloma. Supernatant from wells containing growing cells was screened for IgM by ELISA.
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VH12-transgenic Mice Positive clones were expanded and then subcloned to ensure monoclonality.
Genomic Blot Hybridizations.
To prepare hybridoma DNA, ,~5
x 107 cells were washed in PBS and resuspended in 0.5 ml digestion buffer consisting of 100 mM NaC1, 10 mM Tris-C1, pH 8, 25 mM EDTA, pH 8, 0.5% SDS, and 0.1 mg/ml proteinase K. After an overnight incubation at 50~ the DNA was extracted once with phenol, once with phenol/chloroform (1:1), and once with chloroform. The DNA was then precipitated by adding a half volume of 7.5 M ammonium acetate and 2 vol ethanol. The precipitated DNA was spooled out of the ethanol with a glass rod, rinsed with 70% ethanol, and resuspended in 100 #1 Tris-EDTA (TE). Analysis was by the method of Southern (35) . DNA was digested with BamHI and electrophoresed through 0.7% agarose gels. The DNA was transferred to nitrocellulose and hybridized with the J,-specific probe pEC~ (33 Immunofluorescence and Flow Cytometry. To detect membrane molecules, single-ceU suspensions were prepared in HBSS (without Ca 2+ , Mg 2 § , and phenol red) containing 0.1% sodium azide and 0.5% FCS (buffer). Cells were incubated with previously determined saturating amounts of antibody in 25-50/xl buffer for 20 min, after which they were washed three times with buffer and incubated with second-step reagents. After washing as before, the cells were analyzed with a FACScan | (Becton Dickinson, Mountain View, CA) with acquisition computer and software from Cytomation (Fort Collins, CO), unless otherwise noted. All data represent cells falling within the lymphocyte gate determined by forward and 90 ~ light scatter; 10,000-50,000 cells were analyzed.
ELISA. Detection of V.12 Id, IgM ~ allotype, x light chain, and total IgM were performed by ELISA as previously described (6) . Assays were quantifed with mAb standards of known IgM concentration. Trapping reagents for each analysis were anti-V.12 Id, anti-IgM ~ (DS-1; Pharmingen), goat anti-mouse x, and goat anti-mouse IgM (Southern Biotechnology Associates, Birmingham, AL). Assays were developed with alkaline phosphatase-conjugated goat anti-mouse IgM (Southern Biotechnology Associates).
Results

Tg Mice
The expressed V. and VK rearrangements of the PtC-1587 Arnold et al.
specific B cell lymphoma CH27 (19) were used to generate Tg mice to examine the development of V.12-expressing and PtC-specific B cells. These genes were cloned into C~ (Igh-a) or C~ expression vectors ( Fig. 1) , and separate heavy-and light-chain Tg mice were produced. Four V.12 C~ founder lines were established, and two (7-2 and 6-1) were selected for extensive study. Line 7-2 contains 1-2 copies of the Tg, and 6-1 contains 15-20 copies. Mice have been backcrossed to 2~4 b (IgH b) and are currently in their sixth backcross generation. Two V~4 founder lines have been established; one (1-2) having 5-10 copies has been characterized and used in these experiments. Mice transgenic for both V.12 and VK4 (double Tg) were made by mating 6-1 V,12-Tg females with 1-2 V~4-Tg males.
Characterization of Tg Expression and B Cell Subpopulations in V,12-Tg Mice
Allelic Exclusion. We have analyzed adult peripheral lymphoid tissues from lines 7-2 and 6-1 for cell surface expression of/x chains encoded by the Tg (IgM ~) and an endogenous allele (IgMb). As shown in Figs. 2 and 3, 6-1 mice exclude nearly all expression of endogenous C~. Tg C~ is expressed by >95% of splenic and peritoneal B cells, and <5% of cells express an endogenous C~ (70% of these appear not to express the Tg). In contrast, 7-2 mice appear to express endogenous C~ genes much more frequently. The majority (70-90%) of 7-2 peritoneal cells (PerC) express only the Tg, and 10-30% (variable between individual mice) express both the Tg and an endogenous rearrangement. On the other hand, the majority of 7-2 splenic B cells express an endogenous rearrangement, and about half of these also express low levels of Tg C,. Only m10% of splenic B cells appear to express only the Tg. Allelic exclusion in 1-2 V~-Tg mice was assessed by Southern blot analysis of endogenous J~ rearrangements in splenic LPS hybridomas. Hybridomas with hybridizing fragments in addition to the endogenous germline and Tg fragments were scored as having failed to undergo Tg-mediated allelic exclusion. 12 of 23 (~50%) hybridomas showed no evidence of endogenous V~ gene rearrangements (data not shown). Allelic exclusion in (6-1 x 1-2)FI mice that express both Tgs appears to be predicted by the phenotype of the parents; they express no endogenous heavy chain genes, and (Fig. 2) .
VH12-transgenic Mice
Analysis of Spleen Cells. In line 6-1 and double-Tg mice, essentially all B cells express the Tg without endogenous C,. However, in mice of both these lines, two clearly distinguishable B cell populations are present. The predominant one is mlgM hi, which expresses CDS, binds liposomes, is B220 l~ CD23-, and CD11b- (Figs. 3 and 4) . The other population (larger in 6-1 mice than in double-Tg mice) does not bind liposomes, is mlgM 1~ CDS-, CD23 +, and CDllb-. Three-color flow cytometric analysis of 6-1 splenic cells ( Side Scatter Figure 4 . Three-color immunofluorescence analysis of spleen cells from 6-1 V,12-Tg mice. Cells were stained with carboxyfluorescein liposomes, PE-anti-IgM', and either biotinylated anti-CD5, anti-CD3, anti-B220 (6B2), or anti-CDllb (Mac-l) (revealed with streptavidin-RED670). IgM' + cells were selected for analysis by gating and histograms of liposomes versus CD5, CD23, B220, or CDllb generated. The light scatter histograms were generated by gating on the liposome-positive or -negative populations. The percentages refer to the percent of cells in the box compared with the total liposome-positive or -negative cells as appropriate. The numbers in the single-parameter histograms refer to the mean channel number of the peak (on a 512-channel linear distribution). 35,000 cells were analyzed.
The majority (80-90%) of splenic B cells in 7-2 mice have mostly endogenous heavy chains (Fig. 3) . The number of CD5 § B cells is slightly higher than in normal mice (~l.5-fold), and the number of cells specific for PtC (binding liposomes) are increased ~15-40-fold above normal (Fig. 3) . All of the cells specific for PtC express the Tg. However, since the percentage of Tg + cells that bind liposomes and the percentage of Tg + cells that are CD5 + and B2201~ are similar (11 vs. 15 and 21%, respectively), it is likely that the PtCspecific cells have the cell surface characteristics of B-1 cells (Fig. 3) . Three-color analysis confirms that Tg + tiposomebinding B cells are CD5 +, CD23-, and B220 [~ and Tg + liposome-negative cells are CDS-, CD23 +, and B220 ~ (data not shown).
Expression of V,12-Tg Early in Ontogeny.
Liver and spleen cells of newborn V,12-Tg mice were examined to determine the expression of the Tg and B cell development early in ontogeny (Figs. 5 and 6 ). Newborn livers of both 7-2 and 6-1 mice contain normal numbers of IgM + B cells. In liver and spleen of 7-2 mice, B cells expressing the Tg predominate, the reciprocal of that seen in the adult spleen (Fig. 3 ) and bone marrow (see below). In newborn 6-1 mice, nearly all Ig + B cells express the Tg, as seen in the adult. However, the IgM § B cells present in newborn Tg mice (both 7-2 and 6-1) are not predominantly CD5 + (<5%) ( Fig. 6 ; data not shown for 7-2 mice). In newborn 6-1 mice, 3-5% oflgM + cells bind liposome (Fig. 6 ). In 6-1 mice, liposome-binding IgM + cells increase rapidly, so that by day 3, they represent 15-20% of IgM + cells and, by day 6 >80% of IgM + cells The bone marrow B cell subpopulation distribution from several mice was determined as described in Figs. 6 and 7 and summarized here. The Tgcontrol mice include Tg-mice of the 7-2 line (two mice), 6-1 line (two mice), and 2q b (two mice). No differences were observed among these mice. Table 2 . 6-1 mice have about twofold fewer total B220 + cells and about fourfold fewer Ig + bone marrow B cells than Tg-controls. This is particularly evident in the B220 hi, IgM + population, where the decrease from normal is ninefold, but is also apparent (about threefold) in the less mature B2201~ IgM + population ( Fig. 8 and Table 2 ). Serum Ig in V, d2-Tg Mice. In normal mice, a large proportion of serum IgM is derived from cells of the B-1 population (22, 38) . We have analyzed sera from Tg mice o 100 -for expression of V.12 idiotype and PtC specificity. As ~. shown in Fig. 9 , V.12-Tg mice have high levels of V.12 idio otype in their serum. Line 7-2 mice have '~50-fold more ~-V.12 Id than Tg-mice; 6-1 and double-Tg mice have | 100-200-fold more. All mice have about the same levels of ~ lOtotal serum IgM (800-1,100 #g/ml; data not shown). V.12-g Tg mice also have high levels of serum IgM specific for PtC g @ (anti-BrMRBC), as detected by their ability to bind BrMRBC ,, (Fig. 10) . Thus, the PtC-specific B-1 cells in these mice are secreting substantial amounts of IgM.
Discussion
To examine the selection of PtC-specific B cells and the basis for their segregation to the B-1 population, we have produced Tg mice expressing either the V~12/~ heavy chain or the V~4 light chain used to encode anti-PtC antibodies. We find that V.12-Tg mice have large numbers of B-1 cells in spleen and PerC, almost all of which are specific for PtC. Figure 9 . Sera of Tg mice contain large amounts of V.12 Id + IgM. Serum from young adult mice were analyzed by ELISA for V.12 Id + IgM. For V.12 Id anal-),sis, a rat anti-V.12 Id (specific for the V.12 heavy chain only) was used for trapping, and the binding of serum IgM was revealed with goat anti-mouse IgM-alkaline phosphatase. All mice had equivalent amounts of total serum IgM (800-1,100
/zg/ml; data not shown Figure 10 . Sera of Tg mice contain large amounts oflgM, which binds to BrMRBC. Dilutions of sera (heat treated to inactivate complement) from young adult Tg mice were incubated with BrMRBC. After washing, the binding of IgM was revealed with FITC-goat anti-mouse IgM. Calls (in triplicate) were analyzed with a PACScan | and mean channel fluorescence determined for each sample. The level of IgM anti-BrMRBC is approximately proportional to the amount of V.12 Id in the serum (see Fig. 8 ).
though they can rearrange V.12 (and VA), cannot express it. Three, V.12 may be rearranged and expressed by cells of either lineage, but PtC-specific B-2 cells are either unselected, deleted, or anergized, whereas B-1 cells are selected and clonally expanded. Four, PtC-specific B cells are induced to become B-1 cells because of the nature of their interaction with antigen. The first three possibilities are consistent with the lineage hypothesis, whereas the final possibility is consistent with the induced differentiation hypothesis. The V.12-Tg mice allow us to exclude some of these possibilities.
A mechanism for a process of directed Ig V. gene rearrangement that differs between pre-B cells of the two lineages is unlikely since this would have to include multiple genes, and there are V genes known to be used by B cells of both phenotypes (e.g., Vx and several genes of the J558 V186.2 and V3 subfamilies) (10, 39, 40) . However, there is at least one report that B-1 and B-2 lineage cells may use different sets of V. genes (41) , although selective processes cannot be excluded as an explanation for these data. The data from the V.12-Tg mice demonstrate that this prediction is not necessary. We have provided the appropriately rearranged V.12 gene, with its normally associated regulatory elements, to B cells of all lineages, yet both V.12-expressing B-1 and B-2 (B-0) cells are produced, and PtC-specific B cells appear to belong exclusively to the B-1 subset. Data from the VA mice demonstrate that about half of splenic B cells express this Tg, whereas B-1 cells constitute only 5% of splenic B cells. Therefore, this VA gene is expressed by B-2 cells, and yet PtC-specific B-2 cells are not detectable.
The second prediction, that only B-1 lineage cells can express the V.12 gene, requires that B-1 lineage cells have DNA binding proteins that recognize regulatory elements of a subset of V. and/or V~ genes (e.g., V.12 and VA). The data from the V.12-Tg mice (most easily demonstrated in the 6-1 line mice) prove that, at least, the V.12 and V~4 genes are not such genes, since they are expressed by both B-1 and B-2 (B-0) cells. Therefore, such a proposed mechanism for shaping the B-1 repertoire is unnecessary.
Antigen-driven selective mechanisms, therefore, remain the most likely basis for the restricted and exclusive repertoire of B-1 cells. The high frequency of PtC-specific B cells must be due largely to antigen-driven clonal expansion. Analysis of PtC-specific B cells in normal mice clearly establishes that B cells with this specificity are antigen driven (17, 19) . V, use by B cells of 6-1 Tg mice will be diverse and, thus, the large number of cells specific for PtC in adult peritoneum and spleen must be due in part to antigen-driven clonal expansion of this subset of V.12-expressing B cells. Indeed, selection is so powerful that V.12-only-Tg mice are not substantially different from double-Tg mice in which both V.12 and VK4 are provided. Analysis of splenic B cells of young 6-1 mice indicates that selection proceeds rapidly after birth. PtC-specific B cells of 6-1 neonates constitute <5% of IgM + cells, even though the total number of B cells appears normal. Thus, VK use must be diverse at this stage and the expansion of PtC-specific B cells not significantly advanced. PtCspecific B cells are 15-20% of IgM + cells on day 3, and this frequency increases to ,,o80% of IgM § cells on day 6. This rapid increase in the proportion of PtC-specific B cells could be due to clonal selection and expansion of PtC-specific B cells, or to just the accumulation of PtC-specific B cells from a population of B ceils expressing receptors with diverse specificities. The latter explanation would require the elimination of the vast majority of cells expressing a receptor that is not PtC specific and, thus, the spleens of Tg + mice should contain low numbers of IgM + B cells compared with Tgmice. As shown in Table 1 , they contain the same number. The PtC specificity requires the pairing of a particular V~4 with the V,12 expressed in the Tg mice and, assuming random VK4 use, this would mean that only ,,ol cell in 200 would express a receptor specific for PtC. Thus, for V.12-Tg mice to acquire 2.43 x 106 PtC-specific B cells by day 6 (Table 1) without division of the PtC-specific B cells would require the production of 5 x 10 s B cells (2.43 x 106 x 200), or a production of 108 cells per day. This would mean that the mouse would need to produce ~30-40 times more IgM + cells each day than are contained in the spleen of a 6-d-old mouse (normal or Tg+). Thus, it seems inescapable that PtC-specific B cells increase as a result of clonal selection and proliferation. It is also apparent, however, that the number of total splenic B cells that are not. PtC specific in 6-d-old Tg + mice is only -o17% of the total number of such cells in the Tg-mice. Thus, it is possible that some PtC-negative cells are eliminated, although these data cannot establish this. Selection beginning on or about birth is consistent with our previous analysis of V.12 rearrangements indicating considerable restriction of V. CDR3 sequences in the neonate (42) . Selection of B cells in V.12-Tg mice is substantially different from that studied in Tg mice expressing antibody specific for other self-antigens where the cells are deleted or anergized (for reviews see references 43 and 44) , suggesting that anti-PtC has an important normal function in mice.
However, these data do not formally establish whether these selective processes operate before or after lineage commitment. Under the concept of the lineage hypothesis, PtC-specific B-1 cells could be antigen selected and undergo clonal expansion, whereas PtC-specific B-2 cells could be unable to undergo clonal expansion or be functionally eliminated by clonal deletion or anergy. In the absence of donal expansion, the restrictions in V-(D)-J rearrangement and VK association would limit the frequency of these cells in the repertoire to an undetectable level in normal mice. For the same reasons, PtC-specific B-2 cells that are tolerized by anergy would be undetectable. However, unexpanded or anergized B-2 cells in V.12/VK4 double-Tg mice would be at a detectable frequency (~50% of B cells) since both the rearranged V. and V~ genes are provided. That we do not detect PtC-specific B-2 cells in these mice indicates that neither of these mechanisms is responsible for the absence of B-2 cells with this specificity. Thus, by the lineage hypothesis, the only selective mechanism to exclude the PtC specificity from the B-2 lineage appears to be clonal deletion, either because of a failure to be positively selected in the bone marrow or to negative selection. These data are also consistent with the antigeninduced differentiation hypothesis (24, 25) , which states that newly generated PtC-specific B cells would be selected into the B-1 population. Thus, since PtC is a ubiquitous selfantigen, all B cells with anti-PtC receptors would encounter antigen and be induced to become B-1 cells, and there would be no B-2 (B-0) cells with this specificity. This model is more conservative in that it requires only an additional consequence of mlg receptor signaling. In either case, we conclude that the events leading to the segregation of the PtC specificity to B-1 cells are initiated after Ig gene rearrangement and expression.
The most surprising observation from the analysis of V.12-Tg mice is the decreased numbers of Ig + B cells in adult bone marrow, despite the apparent normal development of Ig § cells very early in ontogeny. This decrease is greater than is apparent from just the comparison of the number of Ig + cells (Table 1) . Many of the Tg + B cells in 7-2 and 6-1 mice are CD5 § and bind liposomes (37 and 47% of Tg + cells, respectively [ Table 1] ). These cells are probably clonally selected mature B-1 cells that have migrated to the bone marrow, since newly generated B cells specific for PtC should be infrequent because of restriction in light chain association for this specificity. Excluding the PtC-specific B cells, the reduction in the number of newly generated B cells from normal is 10-and 8.5-fold in 7-2 and 6-1 mice, respectively.
This reduction in B cell development appears to affect Tgexpressing B cells preferentially. 7-2 mice produce B cells expressing the Tg and B cells expressing an endogenous V. gene (Fig. 6) . In newborn 7-2 mice, 80-90% of B cells are Tg + . Thus, the Tg in these mice appears to exclude endogenous rearrangement well. Since the mechanism of allelic exdusion should not be different in the adult, the fact that the number of Tg + B cells in adult bone marrow is less than half the number of endogenous IgM § B cells suggests that the differentiation of Tg § B cells in the bone marrow is selectively affected. B cells expressing endogenous IgM do not compensate entirely for the reduction in Tg § B cell differentiation, probably because allelic exclusion by the Tg results in relatively few cells expressing endogenous IgM.
We speculate that the impairment of B cell differentiation in these Tg mice may be related to positive selection of developing V,12-expressing B cells. We (25, 42, 45) and others (40, (46) (47) (48) have proposed that developing B cells, like developing T ceils (for reviews see references 49 and 50), require rescue from an inevitable progression to apoptosis by ligand interaction (positive selection). We have recently demonstrated that positive selection of V.12-expressing B cells in normal neonatal and adult mice is dependent on the sequence of V. CDR3 (42 and Ye, J., L. W. Arnold, S. K. McCray, and S. H. Clarke, manuscript in preparation). This selection may occur at the pre-B cell stage and therefore be independent of the light-chain, or it may occur at the immature B cell stage after light chain expression. We have preliminary evidence for the former from sorted IgM-B lineage cells of adult bone marrow (Ye, J., and S. H. Clarke, unpublished observation). There may also be a requirement for positive selection after light-chain expression, and this could explain the loss of a significant fraction of B cells in the bone marrow of V,12-Tg mice if only some V.12/V~ combinations can be rescued. An alternative, but not necessarily mutually exclusive, explanation is that the very high levels of circulating PtC-specific IgM in Tg mice interfere with positive selection of pre-B or B cells by competing with their cell surface Ig receptors for ligand. This idea would also predict the observation that B cell development in neonatal mice would not be disrupted since there would be probably at most only low levels of circulating anti-PtC antibody because of the scarcity of cells with this specificity.
